GetTopicDetailResponse(id=31a61693e61, topicName=sutimlimab, introduction=sutimlimab, content=null, image=null, comments=3, allHits=1067, url=https://h5.medsci.cn/topic?id=16937, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=85290, tagList=[TagDto(tagId=85290, tagName=sutimlimab)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2277074, encodeId=120022e707431, content=<a href='/topic/show?id=4d303113965' target=_blank style='color:#2F92EE;'>#冷凝集素病#</a> <a href='/topic/show?id=31a61693e61' target=_blank style='color:#2F92EE;'>#sutimlimab#</a>, objectTitle=《第二批罕見(jiàn)病目錄》之冷凝集素病——Sutimlimab在疾病中的應(yīng)用, objectType=article, longId=891505, objectId=15f0891505e5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241120/1732065662648_8538692.png, objectUrl=/article/show_article.do?id=15f0891505e5, replyNumber=0, likeNumber=13, createdTime=2025-08-13, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=15f0891505e5, moduleTitle=《第二批罕見(jiàn)病目錄》之冷凝集素病——Sutimlimab在疾病中的應(yīng)用, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=15f0891505e5)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1995788, encodeId=693a1995e8878, content=<a href='/topic/show?id=31a61693e61' target=_blank style='color:#2F92EE;'>#sutimlimab#</a>, objectTitle=Blood：sutimlimab療法改善了冷凝集素病的嚴(yán)重溶血性貧血狀況, objectType=article, longId=212695, objectId=b3da212695ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3da212695ff, replyNumber=0, likeNumber=91, createdTime=2021-06-18, rootId=0, userName=xiongliangxl, userId=84fb152, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3da212695ff, moduleTitle=Blood：sutimlimab療法改善了冷凝集素病的嚴(yán)重溶血性貧血狀況, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b3da212695ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995787, encodeId=c5ef1995e87fa, content=<a href='/topic/show?id=31a61693e61' target=_blank style='color:#2F92EE;'>#sutimlimab#</a>, objectTitle=NEJM：sutimlimab治療冷凝集素病效果喜人, objectType=article, longId=209764, objectId=97d6209e6430, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97d6209e6430, replyNumber=0, likeNumber=95, createdTime=2021-05-30, rootId=0, userName=xiongliangxl, userId=84fb152, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97d6209e6430, moduleTitle=NEJM：sutimlimab治療冷凝集素病效果喜人, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=97d6209e6430)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995786, encodeId=ede81995e869b, content=<a href='/topic/show?id=31a61693e61' target=_blank style='color:#2F92EE;'>#sutimlimab#</a>, objectTitle=ASH19：C1s抑制劑sutimlimab增加原發(fā)性冷凝集素疾病患者的血紅蛋白水平, objectType=article, longId=184566, objectId=f8621845665a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8621845665a, replyNumber=0, likeNumber=78, createdTime=2020-01-09, rootId=0, userName=xiongliangxl, userId=84fb152, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8621845665a, moduleTitle=ASH19：C1s抑制劑sutimlimab增加原發(fā)性冷凝集素疾病患者的血紅蛋白水平, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f8621845665a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
